After Alzheimer’s collapse, Biogen must win Tecfidera patent challenge

After Alzheimer’s collapse, Biogen must win Tecfidera patent challenge

Source: 
EP Vantage
snippet: 

A successful Mylan challenge would see generic entry within two years – though Biogen has fought off copycats before.